top headlines
ViiV Healthcare has secured FDA Priority Review for its application [...]
The UK health watchdog NICE has recommended NHS reimbursement of [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]
bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]
The European Commission has approved BRAFTOVI in combination with cetuximab [...]
African health leaders have launched the Imara Sickle Cell Framework [...]
Houdini Bio has launched a machine learning-guided DNA sequence design [...]
Researchers in Singapore have developed a fluorescent nanosensor capable of [...]
